These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2408232)

  • 1. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow.
    Carmody J; Lilly JK
    W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nimodipine on multiunit activity of several brain structures following acute global cerebral ischemia-anoxia in cats.
    Cervantes M; Chávez-Carrillo I; Antonio-Ocampo A
    Bol Estud Med Biol; 1992; 40(1-4):21-30. PubMed ID: 1296669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimodipine.
    Whitfield PC; Pickard JD
    Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):539-40. PubMed ID: 7858806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nimodipine on brain blood flow following acute brain ischemia in the newborn piglet.
    Easley CS; Wartman FS; Kopelman AE; Louis TM
    Dev Pharmacol Ther; 1992; 18(1-2):65-70. PubMed ID: 1483364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the dihydropyridine calcium channels following cerebral ischemia.
    Hogan M; Gjedde A; Hakim A
    Arzneimittelforschung; 1991 Mar; 41(3A):332-3. PubMed ID: 1650224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo binding of nimodipine in the brain: II. Binding kinetics in focal cerebral ischemia.
    Hogan MJ; Gjedde A; Hakim AM
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):771-8. PubMed ID: 1874809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of calcium entry blocker, nimodipine, on the cerebral function and metabolic recovery following experimental cerebral ischemia].
    Mabe H; Takagi T; Umemura S; Ohno M; Nagai H
    No To Shinkei; 1985 Nov; 37(11):1067-72. PubMed ID: 2934079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
    Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
    Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimodipine Reappraised: An Old Drug With a Future.
    Carlson AP; Hänggi D; Macdonald RL; Shuttleworth CW
    Curr Neuropharmacol; 2020; 18(1):65-82. PubMed ID: 31560289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological influences on cardiopulmonary arrest-related brain damage in the rat.
    Calle PA
    Verh K Acad Geneeskd Belg; 1993; 55(2):123-44. PubMed ID: 8480449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of calcium channel blockers in the management of cerebral ischemia.
    Schaefer MK; Schaefer RF
    Hawaii Med J; 1987 Dec; 46(12):473, 476, 478-9. PubMed ID: 3127355
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nimodipine on acute cerebral ischemia and reperfusion injury of rats.
    He MX; Ke J; Li ZG; Liu FZ
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):309-10. PubMed ID: 9812709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.